Diana Spiegelberg
8PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 12, 2024
Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists.Arun Chandramohan, Hubert Josien, Tsz Ying Yuen
|Mar 16, 2023
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy.Katrine Ingelshed, Diana Spiegelberg, Pavitra Kannan
|Oct 27, 2022
Higher Risk of Recurrence in Patients Treated for Head and Neck Cancer with Low BMI and Elevated Levels of C-Reactive Protein.Diana Spiegelberg, Christer Malmberg, Ylva Tiblom Ehrsson
|Jan 09, 2020
The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts.Sara Lundsten, Diana Spiegelberg, Nakul R Raval
|Jul 21, 2018
The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors.Diana Spiegelberg, Anja C Mortensen, Sara Lundsten
|Nov 04, 2017
CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.Diana Spiegelberg, Johan Nilvebrant
Pageof 2
Frequent Collaborators
3 joint publications
Marika Nestor
1 joint publications
Johan Nilvebrant
1 joint publications
Sara Lundsten
1 joint publications
Nakul R Raval
1 joint publications
Ylva Tiblom Ehrsson
1 joint publications
Pavitra Kannan
1 joint publications
Linnéa Påvénius
1 joint publications
Long Jiang
1 joint publications
Dilraj Lama
1 joint publications
Francisca Castillo
